Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
7.87
+0.12 (1.55%)
At close: May 13, 2025, 4:00 PM
8.26
+0.39 (4.96%)
Pre-market: May 14, 2025, 7:03 AM EDT

Zevra Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
37.3433.7943.0565.47112.354.21
Upgrade
Short-Term Investments
25.2935.7124.6917.38--
Upgrade
Cash & Short-Term Investments
62.6369.567.7482.85112.354.21
Upgrade
Cash Growth
18.81%2.60%-18.24%-26.26%2566.65%30.96%
Upgrade
Accounts Receivable
12.6210.1816.127.191.422.44
Upgrade
Other Receivables
-0.331.261.110.110.14
Upgrade
Receivables
12.6210.5117.388.31.532.58
Upgrade
Inventory
2.561.97----
Upgrade
Prepaid Expenses
3.774.051.821.690.890.66
Upgrade
Restricted Cash
-----0.11
Upgrade
Other Current Assets
----0.290.83
Upgrade
Total Current Assets
81.5786.0386.9492.83115.068.38
Upgrade
Property, Plant & Equipment
2.061.011.531.782.032.39
Upgrade
Long-Term Investments
6.096.01-2015.42-
Upgrade
Goodwill
4.74.74.7---
Upgrade
Other Intangible Assets
67.3868.9969.23---
Upgrade
Long-Term Accounts Receivable
-----0.4
Upgrade
Other Long-Term Assets
10.9111.389.940.720.440.04
Upgrade
Total Assets
172.71178.13172.33115.34132.9411.21
Upgrade
Accounts Payable
17.8213.0813.993.610.521.17
Upgrade
Accrued Expenses
5.1717.3718.977.212.525.47
Upgrade
Short-Term Debt
--37.7---
Upgrade
Current Portion of Long-Term Debt
-----0.39
Upgrade
Current Portion of Leases
0.590.420.540.490.370.5
Upgrade
Other Current Liabilities
3.43.22.520.710.82-
Upgrade
Total Current Liabilities
26.9834.0773.7212.024.237.54
Upgrade
Long-Term Debt
60.0959.55.0712.8-68.05
Upgrade
Long-Term Leases
1.160.370.460.841.241.61
Upgrade
Other Long-Term Liabilities
43.4644.5231.2214.550.360.43
Upgrade
Total Liabilities
131.69138.46110.4640.225.8277.62
Upgrade
Common Stock
0.010.01000-
Upgrade
Additional Paid-In Capital
560.47555.3472.66436.27396.96192.06
Upgrade
Retained Earnings
-508.39-505.29-399.78-353.73-267.03-258.47
Upgrade
Treasury Stock
-10.98-10.98-10.98-7.54-2.81-
Upgrade
Comprehensive Income & Other
-0.080.63-0.040.11--
Upgrade
Total Common Equity
41.0239.6761.8675.12127.12-66.41
Upgrade
Shareholders' Equity
41.0239.6761.8675.12127.12-66.41
Upgrade
Total Liabilities & Equity
172.71178.13172.33115.34132.9411.21
Upgrade
Total Debt
61.8460.343.7714.131.6170.55
Upgrade
Net Cash (Debt)
0.799.223.9768.72110.74-66.33
Upgrade
Net Cash Growth
-90.58%-61.62%-65.11%-37.95%--
Upgrade
Net Cash Per Share
0.020.200.681.993.72-16.66
Upgrade
Filing Date Shares Outstanding
54.6854.1241.8534.5434.4228.38
Upgrade
Total Common Shares Outstanding
54.6853.6741.5334.5435.014.54
Upgrade
Working Capital
54.651.9613.2280.81110.830.85
Upgrade
Book Value Per Share
0.750.741.492.173.63-14.64
Upgrade
Tangible Book Value
-31.06-34.03-12.0675.12127.12-66.41
Upgrade
Tangible Book Value Per Share
-0.57-0.63-0.292.173.63-14.64
Upgrade
Machinery
-1.361.511.281.051.01
Upgrade
Leasehold Improvements
-0.710.710.710.720.72
Upgrade
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q